These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 8852405

  • 1. Vaccination with a cocktail of seven recombinantly expressed HSV-1 glycoproteins protects against ocular HSV-1 challenge more efficiently than vaccination with any individual glycoprotein.
    Ghiasi H, Nesburn AB, Wechsler SL.
    Vaccine; 1996 Feb; 14(2):107-12. PubMed ID: 8852405
    [Abstract] [Full Text] [Related]

  • 2. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice.
    Ghiasi H, Kaiwar R, Nesburn AB, Slanina S, Wechsler SL.
    J Virol; 1994 Apr; 68(4):2118-26. PubMed ID: 8138996
    [Abstract] [Full Text] [Related]

  • 3. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins.
    Ghiasi H, Bahri S, Nesburn AB, Wechsler SL.
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1352-60. PubMed ID: 7775113
    [Abstract] [Full Text] [Related]

  • 4. Enhanced protection against HSV lethal challenges in mice by immunization with a combined HSV-1 glycoprotein B:H:L gene DNAs.
    Cha SC, Kim YS, Cho JK, Cho J, Kim SY, Kang H, Cho MH, Lee HH.
    Virus Res; 2002 Jun; 86(1-2):21-31. PubMed ID: 12076826
    [Abstract] [Full Text] [Related]

  • 5. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge.
    Ghiasi H, Cai S, Slanina S, Nesburn AB, Wechsler SL.
    Antiviral Res; 1995 Oct; 28(2):147-57. PubMed ID: 8585768
    [Abstract] [Full Text] [Related]

  • 6. Vaccination with different HSV-1 glycoproteins induces different patterns of ocular cytokine responses following HSV-1 challenge of vaccinated mice.
    Ghiasi H, Hofman FM, Cai S, Perng GC, Nesburn AB, Wechsler SL.
    Vaccine; 1999 Jun 04; 17(20-21):2576-82. PubMed ID: 10418905
    [Abstract] [Full Text] [Related]

  • 7. Herpes Simplex Virus 1 (HSV-1) 0ΔNLS Live-Attenuated Vaccine Protects against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice.
    Gmyrek GB, Filiberti A, Montgomery M, Chitrakar A, Royer DJ, Carr DJJ.
    J Virol; 2020 Nov 23; 94(24):. PubMed ID: 32999018
    [Abstract] [Full Text] [Related]

  • 8. Characterization of baculovirus-expressed herpes simplex virus type 1 glycoprotein K.
    Ghiasi H, Slanina S, Nesburn AB, Wechsler SL.
    J Virol; 1994 Apr 23; 68(4):2347-54. PubMed ID: 8139020
    [Abstract] [Full Text] [Related]

  • 9. Corneal macrophage infiltrates following ocular herpes simplex virus type 1 challenge vary in BALB/c mice vaccinated with different vaccines.
    Ghiasi H, Hofman FM, Wallner K, Cai S, Perng G, Nesburn AB, Wechsler SL.
    Vaccine; 2000 Dec 08; 19(9-10):1266-73. PubMed ID: 11137266
    [Abstract] [Full Text] [Related]

  • 10. The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge.
    Ghiasi H, Roopenian DC, Slanina S, Cai S, Nesburn AB, Wechsler SL.
    Immunology; 1997 Jul 08; 91(3):430-5. PubMed ID: 9301533
    [Abstract] [Full Text] [Related]

  • 11. Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-based immunisation with herpes simplex virus type-1 genes specifying glycoproteins gB and gD.
    Baghian A, Chouljenko VN, D'Auvergne O, Newman MJ, Baghian S, Kousoulas KG.
    J Med Microbiol; 2002 Apr 08; 51(4):350-357. PubMed ID: 11926742
    [Abstract] [Full Text] [Related]

  • 12. The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge.
    Ghiasi H, Wechsler SL, Cai S, Nesburn AB, Hofman FM.
    Immunology; 1998 Nov 08; 95(3):352-9. PubMed ID: 9824497
    [Abstract] [Full Text] [Related]

  • 13. Specific and nonspecific immune stimulation of MHC-II-deficient mice results in chronic HSV-1 infection of the trigeminal ganglia following ocular challenge.
    Ghiasi H, Perng GC, Hofman FM, Cai S, Nesburn AB, Wechsler SL.
    Virology; 1999 Jun 05; 258(2):208-16. PubMed ID: 10366558
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines.
    Osorio Y, Cohen J, Ghiasi H.
    Invest Ophthalmol Vis Sci; 2004 Feb 05; 45(2):506-14. PubMed ID: 14744892
    [Abstract] [Full Text] [Related]

  • 16. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge.
    Peng T, Ponce-de-Leon M, Jiang H, Dubin G, Lubinski JM, Eisenberg RJ, Cohen GH.
    J Virol; 1998 Jan 05; 72(1):65-72. PubMed ID: 9420201
    [Abstract] [Full Text] [Related]

  • 17. Baculovirus-expressed glycoprotein E (gE) of herpes simplex virus type-1 (HSV-1) protects mice against lethal intraperitoneal and lethal ocular HSV-1 challenge.
    Ghiasi H, Kaiwar R, Nesburn AB, Slanina S, Wechsler SL.
    Virology; 1992 Jun 05; 188(2):469-76. PubMed ID: 1585630
    [Abstract] [Full Text] [Related]

  • 18. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
    Karem KL, Bowen J, Kuklin N, Rouse BT.
    J Gen Virol; 1997 Feb 05; 78 ( Pt 2)():427-34. PubMed ID: 9018066
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits.
    Nesburn AB, Burke RL, Ghiasi H, Slanina SM, Wechsler SL.
    Virology; 1998 Dec 05; 252(1):200-9. PubMed ID: 9875329
    [Abstract] [Full Text] [Related]

  • 20. Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1.
    Ghiasi H, Wechsler SL, Kaiwar R, Nesburn AB, Hofman FM.
    J Virol; 1995 Jan 05; 69(1):334-40. PubMed ID: 7983727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.